291_parsons(2).pdf (57.25 kB)
0/0

What drives pharmaceutical innovation and knowledge exchange? A study supporting the use of Knowledge Management within the pharmaceutical industry

Download (57.25 kB)
conference contribution
posted on 28.04.2017 by Thomas W. Parsons, Tom Jackson, Ray Dawson
Innovation is a key driver of the pharmaceutical company, from an initial discovery of a compound to the final development of a marketable and novel medicine, the web of processes to reach a viable end stage requires innovative behaviour backed by accurate knowledge. This paper analyses the use, importance and sources of knowledge within the drug development process and suggests that a pharmaceutical Knowledge Management strategy should not only address capturing the knowledge within the drug processes, but also the knowledge held within the social networks of the organisation.

History

School

  • Business and Economics

Department

  • Business

Published in

First International Conference on Organisational Learning, Knowledge and Capabilities, OLKC 2006 URL: http://www2.warwick.ac.uk/fac/soc/wbs/conf/olkc/archive/olkc1/papers/291_parsons.pdf

Volume

1

Pages

? - ? (16)

Citation

PARSONS, T.W., JACKSON, T. and DAWSON, R., 2006. What drives pharmaceutical innovation and knowledge exchange? A study supporting the use of Knowledge Management within the pharmaceutical industry. First International Conference on Organisational Learning, Knowledge and Capabilities, OLKC 2006, Coventry, 20th-22nd March, 16pp.

Publisher

University of Warwick

Version

VoR (Version of Record)

Publisher statement

This work is made available according to the conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. Full details of this licence are available at: https://creativecommons.org/licenses/by-nc-nd/4.0/

Publication date

2006

Notes

This is a conference paper.

Language

en

Location

Coventry

Exports

Logo branding

Exports